Dietary fiber, gut microbiota, and metabolic regulation—Current status in human randomized trials MCW Myhrstad, H Tunsjø, C Charnock, VH Telle-Hansen Nutrients 12 (3), 859, 2020 | 235 | 2020 |
Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis LL Gundersen, C Charnock, AH Negussie, F Rise, S Teklu European journal of pharmaceutical sciences 30 (1), 26-35, 2007 | 173 | 2007 |
Assimilable organic carbon and biodegradable dissolved organic carbon in Norwegian raw and drinking waters C Charnock, O Kjønnø Water Research 34 (10), 2629-2642, 2000 | 142 | 2000 |
A preliminary study on the potential of Nanopore MinION and Illumina MiSeq 16S rRNA gene sequencing to characterize building-dust microbiomes AB Nygaard, HS Tunsjø, R Meisal, C Charnock Scientific Reports 10 (1), 3209, 2020 | 135 | 2020 |
Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs A Vik, E Hedner, C Charnock, LW Tangen, Ø Samuelsen, R Larsson, ... Bioorganic & medicinal chemistry 15 (12), 4016-4037, 2007 | 103 | 2007 |
(+)-Agelasine D: improved synthesis and evaluation of antibacterial and cytotoxic activities A Vik, E Hedner, C Charnock, Ø Samuelsen, R Larsson, LL Gundersen, ... Journal of natural products 69 (3), 381-386, 2006 | 85 | 2006 |
Are multidose over-the-counter artificial tears adequately preserved? C Charnock Cornea 25 (4), 432-437, 2006 | 82 | 2006 |
Combining esters of para‐hydroxy benzoic acid (parabens) to achieve increased antimicrobial activity C Charnock, T Finsrud Journal of clinical pharmacy and therapeutics 32 (6), 567-572, 2007 | 81 | 2007 |
Evaluation of the antibacterial efficacy of diesters of azelaic acid C Charnock, B Brudeli, J Klaveness European journal of pharmaceutical sciences 21 (5), 589-596, 2004 | 78 | 2004 |
Synthesis, Antimicrobial and Antineoplastic Activities for Agelasine and Agelasimine Analogs with a β‐Cyclocitral Derived Substituent A Proszenyak, C Charnock, E Hedner, R Larsson, L Bohlin, ... Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2007 | 47 | 2007 |
Swabbing of waiting room magazines reveals only low levels of bacterial contamination C Charnock British journal of general practice 55 (510), 37-39, 2005 | 44 | 2005 |
Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring AD Khoje, A Kulendrn, C Charnock, B Wan, S Franzblau, LL Gundersen Bioorganic & medicinal chemistry 18 (20), 7274-7282, 2010 | 41 | 2010 |
Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles AD Khoje, C Charnock, B Wan, S Franzblau, LL Gundersen Bioorganic & medicinal chemistry 19 (11), 3483-3491, 2011 | 38 | 2011 |
Microbial quality and nutritional aspects of Norwegian brand waters E Otterholt, C Charnock International journal of food microbiology 144 (3), 455-463, 2011 | 34 | 2011 |
Antimicrobial and Antineoplastic Activities of Agelasine Analogs Modified in the Purine 2‐Position H Roggen, C Charnock, R Burman, J Felth, R Larsson, L Bohlin, ... Archiv der Pharmazie 344 (1), 50-55, 2011 | 33 | 2011 |
Synthesis and antimycobacterial activity of 5-formylaminopyrimidines; analogs of antibacterial purines M Brændvang, C Charnock, LL Gundersen Bioorganic & medicinal chemistry letters 19 (12), 3297-3299, 2009 | 32 | 2009 |
The first synthesis of ent-agelasine F Á Proszenyák, M Brændvang, C Charnock, LL Gundersen Tetrahedron 65 (1), 194-199, 2009 | 32 | 2009 |
Activity of 6-aryl-pyrrolo [2, 3-d] pyrimidine-4-amines to Tetrahymena SJ Kaspersen, E Sundby, C Charnock, BH Hoff Bioorganic chemistry 44, 35-41, 2012 | 30 | 2012 |
Longitudinal development of the dust microbiome in a newly opened Norwegian kindergarten AB Nygaard, C Charnock Microbiome 6, 1-11, 2018 | 29 | 2018 |
Identification and phylogeny of the small eukaryote population of raw and drinking waters E Otterholt, C Charnock Water research 45 (8), 2527-2538, 2011 | 28 | 2011 |